Invivyd Announces Initiation of DECLARATION Clinical Trial, a Phase 3 Placebo-Controlled Pivotal Study of VYD2311, a Vaccine-Alternative Antibody to Prevent COVID

DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of COVID ...
Discover Magazine on MSN

Traditional Chinese medicine works surprisingly well when treating diabetic kidney disease

Discover how a traditional Chinese herbal mix showed better results in treating a common kidney disease compared to commonly ...
EurekAlert!

Clinical trials on AI language model use in digestive healthcare

This scoping review identifies the first wave of randomized controlled trials testing large language models in digestive diseases. Four published and ten ongoing trials suggest that AI tools such as ...
Business Wire

Journal of the American Medical Association (JAMA) Publishes Results from First-Ever Randomized, Placebo-Controlled Clinical Trial Assessing the Dose-Dependent Efficacy of ...

The Phase 2b study demonstrated a statistically significant dose-response relationship at the primary endpoint following a single administration of MM120 across four dose levels, with improvements ...